Navigation Links
NxStage Names Robert G. Funari Chairman Of The Board
Date:4/25/2013

LAWRENCE, Mass., April 25, 2013 /PRNewswire/ -- NxStage Medical, Inc.® (NASDAQ: NXTM) announced today that Robert G. Funari has been appointed as the non-executive Chairman of the Board effective immediately.  Mr. Funari is the former Chairman of Crescent Healthcare and has served on the NxStage Board of Directors since January 2013.

(Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO )

Mr. Funari succeeds Dr. Philippe Chambon , who resigned after having served on the Company's Board of Directors since 1998. 

"It has been one of the great privileges of my career to be involved with the startup of NxStage and to participate in its growth over so many years," stated Dr. Chambon. "Together with Jeff, both the Board and management team have the skill and resources to continue building a great company and the story is only just beginning to unfold."

"We are very grateful to Philippe for his significant contributions to NxStage, commencing with our formation in 1998, and for the continued strategic guidance and valuable service he has given to the Company during his time as Chairman," stated Jeffrey H. Burbank , Founder and CEO of NxStage. "We look forward to working closely with Bob Funari as our new Chairman. I am confident that his leadership and oversight will add significant value to our strategic growth initiatives."

"I am honored to be elected Chairman of NxStage's Board," said Robert Funari . "I am eager to continue working with Jeff and the rest of the management team as they execute their growth strategy with the goal of both expanding access to NxStage's life changing therapy and increasing shareholder value."

Mr. Funari brings to the position an extensive background, including more than 40 years of executive leadership, particularly in the healthcare industry, and a proven track record of strategic planning and implementation.  Mr. Funari served as a director of Beckman Coulter , Inc., a diagnostics and life sciences company, from 2005 to 2011, as well as director of Pope and Talbot, Inc. from 2001 to 2008.  In addition, he served as director of First Consulting Group from 2004 to 2008 and director of Bay Cities National Bank from 1994 to 2011, where he also served as chairman from 2007 to 2011.  He currently sits on the board of directors of a number of non-profit and private companies and is a member of the RAND Healthcare Board of Advisors.

About NxStage Medical

NxStage is a medical device company, headquartered in Lawrence, MA, USA, which develops, manufactures, and markets innovative systems for the treatment of end-stage renal disease (ESRD), and acute kidney failure. The System One home hemodialysis device developed by NxStage is the only FDA approved portable hemodialysis machine cleared for home use. For more information on NxStage, or NxStage products, visit, http://www.nxstage.com.

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including those that are discussed in NxStage's filings with the Securities and Exchange Commission, including the Annual Report on Form 10-K for the year ended December 31, 2012. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

Kristen K. Sheppard, Esq.
VP, Investor Relations
ksheppard@nxstage.com


'/>"/>
SOURCE NxStage Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. NxStage Completes Move to Direct Sales In UK
2. NxStage Educational Reception at Annual Dialysis Conference Features Celebrity and Former NxStage User Stephen Furst
3. NxStage Reports Record Fourth Quarter and Full-Year 2012 Financial Results
4. NxStage Announces CE Mark Approval, First Clinical Use of its Single Needle for Dialysis Patients
5. NxStage Announces CE Mark Approval for New High Flow Capabilities with System One
6. NxStage Announces CE Mark Approval for Nocturnal Home Hemodialysis
7. NxStage Initiates 2013 Call to Action Campaign with Launch of Hemodialysis At Home: A Better Way For a Better Life
8. NxStage Home Hemodialysis Patient Awareness Tour Kicks Off January 29th
9. Robert Funari Joins NxStage Board of Directors
10. NxStage Announces Fourth Quarter 2012 Investor Conference Schedule
11. NxStage Reports Record Revenue for the Third Quarter of Fiscal 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... 2016   Click here for supplemental information ... DPLO), the nation,s largest independent specialty pharmacy, announced ... to acquire Valley Campus Pharmacy, Inc., doing business ... specialty pharmacy that provides individualized patient care, based ... In 2015, TNH generated approximately $400 million in ...
(Date:4/28/2016)... , April 28, 2016  The blood testing market ... dollars, according to Kalorama Information and The Freedonia Group ... and nucleic acid testing.  The healthcare research firm said ... in developing blood collection stations and in improving testing ... Kalorama Information,s report, Blood Testing Market in ...
(Date:4/28/2016)... N.J. , April 28, 2016   Acsis ... today announced that leading IT market research and advisory ... " in the IDC MarketScape: Worldwide Pharmaceutical Track and ... 2016).  The report provides an assessment of the capabilities ... track and trace software market. Logo - ...
Breaking Medicine Technology:
(Date:5/2/2016)... ... May 02, 2016 , ... For many artists, the ... Curt Walter has developed it into a science. , Using the new, highly ... subtly differentiated shades that add depth and meaning to his works. What’s more, it ...
(Date:5/2/2016)... ... May 02, 2016 , ... In response to recent growth and a ... Vision and Blindness (NELV&B) , announces the opening of a new low vision showroom ... vision impairments to get assessments, hands-on experience and training with low vision and blindness ...
(Date:5/1/2016)... ... May 01, 2016 , ... ... that gives new mothers a better understanding of what to expect after they ... Adjusting to baby postpartum, · The blues and depression, · Breastfeeding beyond postpartum ...
(Date:4/30/2016)... ... 30, 2016 , ... Create an abstract shape animation with ... manipulate three-dimensional shapes with ease all within Apple Motion . Users have ... texture animation, opacity texture animation, overall shape texture displacement, twist, camera controls, and ...
(Date:4/30/2016)... ... April 30, 2016 , ... ... questioned the use of the HyProCure sinus tarsi implant. ( http://www.cbc.ca/news/canada/ottawa/banned-quebec-dentist-pierre-dupont-working-as-chiropodist-in-ottawa-1.3515494 ) ... is a minimally invasive procedure performed, when indicated, to correct the partial ...
Breaking Medicine News(10 mins):